Accelerate Diagnostics, Inc. (LON:0H8E)

London · Delayed Price · Currency is GBP · Price in USD

0.0126

+0.0001 (0.80%)

At close: May 22, 2025

Verve Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-50.05	-61.62	-62.49	-77.7	-78.21	Upgrade
Depreciation & Amortization	3.42	3.25	3	2.52	3	Upgrade
Other Amortization	8.68	4.31	1.31	11.54	11.17	Upgrade
Loss (Gain) From Sale of Assets	0.2	0.15	0.13	-0.08	0.79	Upgrade
Loss (Gain) From Sale of Investments	-0.07	-0.11	0.31	0.23	0.1	Upgrade
Stock-Based Compensation	4.38	5.39	10.63	22.05	16.46	Upgrade
Provision & Write-off of Bad Debts	0.35	0.3	0.2	0.12	-	Upgrade
Other Operating Activities	6.29	3.2	-3.57	-5.29	-	Upgrade
Change in Accounts Receivable	0.44	-0.23	-0.1	-0.89	1.59	Upgrade
Change in Inventory	-0.05	0.45	-0.24	-0.42	-1.36	Upgrade
Change in Accounts Payable	0.79	0.3	2.92	0.27	-1.01	Upgrade
Change in Unearned Revenue	1.25	2.12	0.1	0.08	0.11	Upgrade
Change in Other Net Operating Assets	0.16	2.31	-0.93	0.25	-3.04	Upgrade
Operating Cash Flow	-24.19	-40.2	-48.73	-47.32	-50.39	Upgrade
Capital Expenditures	-0.51	-1.04	-0.55	-0.6	-1.36	Upgrade
Investment in Securities	-	9.7	12.97	8.91	14.97	Upgrade
Investing Cash Flow	-0.51	8.66	12.42	8.3	13.61	Upgrade
Long-Term Debt Issued	25.23	10	-	-	5.58	Upgrade
Long-Term Debt Repaid	-1.45	-1.25	-1.28	-0.36	-0.37	Upgrade
Net Debt Issued (Repaid)	23.78	8.75	-1.28	-0.36	5.21	Upgrade
Issuance of Common Stock	5.27	4	33.1	34.67	6.42	Upgrade
Repurchase of Common Stock	-	-	-	-20.3	-	Upgrade
Other Financing Activities	-2	-3.73	-0.19	-1.24	-	Upgrade
Financing Cash Flow	27.05	9.02	31.63	43.23	11.63	Upgrade
Foreign Exchange Rate Adjustments	0.61	-0.25	-0.31	-0.09	-0.08	Upgrade
Net Cash Flow	2.96	-22.77	-4.99	4.12	-25.23	Upgrade
Free Cash Flow	-24.7	-41.23	-49.28	-47.93	-51.76	Upgrade
Free Cash Flow Margin	-211.17%	-341.91%	-386.47%	-406.77%	-463.56%	Upgrade
Free Cash Flow Per Share	-1.06	-3.31	-6.00	-7.76	-9.24	Upgrade
Cash Interest Paid	0.03	0.12	2.21	4.29	4.29	Upgrade
Cash Income Tax Paid	-	0.36	-	-	0.04	Upgrade
Levered Free Cash Flow	-4.67	-25.94	-25.97	-14.65	-22.12	Upgrade
Unlevered Free Cash Flow	-5.15	-25.41	-24.92	-16.48	-23.57	Upgrade
Change in Net Working Capital	-9.62	-0.75	-1.27	-4.28	2.11	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.